A21S (p.Ala21Ser) variant of SCN9A (Nav1.7)
A21S (p.Ala21Ser) in SCN9A (Nav1.7) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes variant effect predictions and structural context.
A21S (p.Ala21Ser) variant details
- p.Ala21Ser
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- MetaLR 0.94
- MetaSVM 1.04
- SIFT 0.00
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available